The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Racial/ethnic differences in drug disposition and response: Review of recently approved drugs
Abstract
Race and ethnicity can contribute to interindividual differences in drug exposure and/or response, which may alter risk–benefit in certain populations. Approximately one‐fifth of new drugs approved in the past 6 years demonstrated differences in exposure and/or response across racial/ethnic groups, translating to population‐specific prescribing recommendations in a few cases. When data from diverse populations were lacking, additional postmarketing studies were recommended. In this review we highlight several cases where race/ethnicity was central to regulatory decision‐making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
Bradford, L. D. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.2.229 · Cited by 773
Nkhoma, E. T., Poole, C., Vannappagari, V., Hall, S. A., & Beutler, E. (2009) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2008.12.005 · Cited by 711
Sequist, L. V., Bell, D. W., Lynch, T. J., & Haber, D. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3585 · Cited by 624
Exner, D. V., Dries, D. L., Domanski, M. J., & Cohn, J. N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441802 · Cited by 567
Howes, R. E., Piel, F. B., Patil, A. P., Nyangiri, O. A., Gething, P. W., Dewi, M., Hogg, M. M., Battle, K. E., Padilla, C. D., Baird, J. K., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001339 · Cited by 562
The genetics of Mexico recapitulates Native American substructure and affects biomedical traits
Moreno-Estrada, A., Gignoux, C. R., Fernández-López, J. C., Zakharia, F., Sikora, M., Contreras, A. V., Acuña-Alonzo, V., Sandoval, K., Eng, C., Romero-Hidalgo, S., et al. (2014) · Science · doi:10.1126/science.1251688 · Cited by 478
Chen, M. S., Lara, P. N., Dang, J. H. T., Paterniti, D. A., & Kelly, K. (2014) · Cancer · doi:10.1002/cncr.28575 · Cited by 472
The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies
Yasuda, S., Zhang, L., & Huang, S.-M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.141 · Cited by 393
Self-citationRace and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure
Yancy, C. W., Fowler, M. B., Colucci, W. S., Gilbert, E. M., Bristow, M. R., Cohn, J. N., Lukas, M. A., Young, S. T., & Packer, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441803 · Cited by 288
Association of a Low-Frequency Variant in HNF1A With Type 2 Diabetes in a Latino Population
Estrada, K., Aukrust, I., Bjørkhaug, L., Burtt, N. P., Mercader, J. M., García-Ortiz, H., Huerta-Chagoya, A., Moreno-Macías, H., Walford, G., Flannick, J., et al. (2014) · JAMA · doi:10.1001/jama.2014.6511 · Cited by 259
Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy
Ingelman‐Sundberg, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00879.x · Cited by 242
Myrand, S., Sekiguchi, K., Man, M., Lin, X., Tzeng, R.-Y., Teng, C.-H., Hee, B., Garrett, M., Kikkawa, H., Lin, C.-Y., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100482 · Cited by 224
Kim, K., Johnson, J. A., & Derendorf, H. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004268128 · Cited by 220
Ancestry and Disease in the Age of Genomic Medicine
Rotimi, C. N., & Jorde, L. B. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0911564 · Cited by 219
Layden-Almer, J. E., Ribeiro, R. M., Wiley, T., Perelson, A. S., & Layden, T. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50217 · Cited by 184
Sm, H., & Temple, R. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.144 · Cited by 157
Ethnic or Racial Differences Revisited
Chen, M. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00001 · Cited by 153
A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness
Bjornsson, T. D., Wagner, J. A., Donahue, S., Harper, D. M., Karim, A., Khouri, M. S., Murphy, W. R. C., Roman, K., Schneck, D. W., Sonnichsen, D. S., et al. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003256065 · Cited by 141
Emerging ethnic differences in lung cancer therapy
Sekine, I., Yamamoto, N., Nishio, K., & Saijo, N. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604721 · Cited by 128
Weir, M. R., Chrysant, S. G., McCarron, D. A., Canossa-Terris, M. A., Cohen, J. D., GUNTER, P. A., Lewin, A. J., Mennella, R. F., Kirkegaard, L. W., Hamilton, J., et al. (1998) · Hypertension · doi:10.1161/01.hyp.31.5.1088 · Cited by 128
The impact of ethnicity on response to antihypertensive therapy
Jamerson, K., & DeQuattro, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00265-3 · Cited by 109
Evelyn, B., Toigo, T., Banks, D., Pohl, D. J., Gray, K., Robins, B., & Ernat, J. J. (2001) · PubMed Central · Cited by 105
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in U.S. Army Personnel
Chinevere, T. D., Murray, C. K., Grant, E., Johnson, G. A., Duelm, F., & Hospenthal, D. R. (2006) · Military Medicine · doi:10.7205/milmed.171.9.905 · Cited by 101
Population Structure of Hispanics in the United States: The Multi-Ethnic Study of Atherosclerosis
Manichaikul, A. W., Palmas, W., Rodríguez, C. J., Peralta, C. A., Divers, J., Guo, X., Chen, W., Wong, Q., Williams, K., Kerr, K. F., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002640 · Cited by 96
Exploring Differences in Drug Doses Between Japan and Western Countries
Arnold, F. L., Kusama, M., & Ono, S. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.31 · Cited by 67
Ichimaru, K., Toyoshima, S., & Uyama, Y. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.285 · Cited by 53
The Genetics of Human Populations.
Hajnal, J., Cavalli-Sforza, L. L., & Bodmer, W. F. (1973) · Population Studies · doi:10.2307/2173465 · Cited by 36
Li, C., Wei, R., Jones‐Hall, Y., Vittal, R., Zhang, M., & Liu, W. (2014) · Scientific Reports · doi:10.1038/srep04893 · Cited by 31
Cited by
Increasing Diversity in Clinical Trials: Overcoming Critical Barriers
Clark, L. T., Watkins, L., Piña, I. L., Elmer, M., Akinboboye, O., Gorham, M., Jamerson, B., McCullough, C., Pierre, C., Polis, A. B., et al. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.11.002 · Cited by 731
Recalibrating the use of race in medical research
Ioannidis, J. P. A., Powe, N. R., & Yancy, C. (2021) · JAMA · doi:10.1001/jama.2021.0003 · Cited by 296
Indorewalla, K. K., O’Connor, M. K., Budson, A. E., Guess (DiTerlizzi), C., & Jackson, J. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201081 · Cited by 93
Schaniel, C., Dhanan, P., Hu, B., Xiong, Y., Raghunandan, T., Gonzalez, D. M., Dariolli, R., D'Souza, S. L., Yadaw, A. S., Hansen, J., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.10.005 · Cited by 26
Perceptions and Preferences Regarding Multiple Sclerosis Research Among Racial and Ethnic Groups
Pimentel Maldonado, D. A., Moreno, A., Williams, M. J., Amezcua, L., Feliciano, S., Williams, A., Machemer, D., Livingston, T., LaRocque, M., Glim, M., et al. (2021) · International Journal of MS Care · doi:10.7224/1537-2073.2019-131 · Cited by 29
Metadata
- Authors
- Ramamoorthy, A., Pacanowski, M., Bull, J., & Zhang, L.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2015-01-20
- Volume
- 97
- Issue
- 3
- Pages
- 263-273
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2049320250
- Cited by
- 341
- References
- 30
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.